UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Implications of CYP2D6 Genotypes Predictive of Tamoxifen Pharmacokinetics in Metastatic Breast Cancer

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3837-3845

2007

Volltextzugriff (PDF)

Preoperative Chemoradiation With Cetuximab, Irinotecan, and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: A Multicenter Phase II Study

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.677-683

2011

Volltextzugriff (PDF)

Fatal Progression of Gorham Disease: A Case Report and Review of the Literature

Journal of oral and maxillofacial surgery, 2015-12, Vol.73 (12), p.2352-2360

2015

Volltextzugriff (PDF)

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

Breast cancer research and treatment, 2008-03, Vol.108 (2), p.241-250

2008

Volltextzugriff (PDF)

Effects of Second and Subsequent Lines of Chemotherapy for Metastatic Breast Cancer

Clinical breast cancer, 2015-02, Vol.15 (1), p.e55-e62

2015

Volltextzugriff (PDF)

Genome‐wide association study of genetic variants related to anthracycline‐induced cardiotoxicity in early breast cancer

Cancer science, 2020-07, Vol.111 (7), p.2579-2587

2020

Volltextzugriff (PDF)

Mutation analysis using cell-free DNA for endocrine therapy in patients with HR+ metastatic breast cancer

Scientific reports, 2021-03, Vol.11 (1), p.5566-5566, Article 5566

2021

Volltextzugriff (PDF)

Symptom perception and functioning in patients with advanced cancer

PloS one, 2021-02, Vol.16 (2), p.e0245987-e0245987

2021

Volltextzugriff (PDF)

Metaplastic breast cancer: clinicopathological features and its prognosis

Journal of clinical pathology, 2012-05, Vol.65 (5), p.441-446

2012

Volltextzugriff (PDF)

Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1732-1739

2013

Volltextzugriff (PDF)

Web-Based Tailored Education Program for Disease-Free Cancer Survivors With Cancer-Related Fatigue: A Randomized Controlled Trial

Journal of clinical oncology, 2012-04, Vol.30 (12), p.1296-1303

2012

Volltextzugriff (PDF)

Comparison of Sentinel Lymph Node Biopsy Guided by the Multimodal Method of Indocyanine Green Fluorescence, Radioisotope, and Blue Dye Versus the Radioisotope Method in Breast Cancer: A Randomized Controlled Trial

Annals of surgical oncology, 2014-04, Vol.21 (4), p.1254-1259

2014

Volltextzugriff (PDF)

Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients

Breast cancer research and treatment, 2014-11, Vol.148 (1), p.91-98

2014

Volltextzugriff (PDF)

Efficacy of exemestane after nonsteroidal aromatase inhibitor use in metastatic breast cancer patients

Asian Pacific journal of cancer prevention : APJCP, 2012-01, Vol.13 (3), p.979-983

2012

Volltextzugriff (PDF)

Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer

Breast cancer research and treatment, 2010-04, Vol.120 (3), p.627-637

2010

Volltextzugriff (PDF)

Health-Related Quality of Life in Survivors With Breast Cancer 1 Year After Diagnosis Compared With the General Population: A Prospective Cohort Study

Annals of surgery, 2011, Vol.253 (1), p.101-108

2011

Volltextzugriff (PDF)

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

Breast cancer research : BCR, 2021-01, Vol.23 (1), p.8-8, Article 8

2021

Volltextzugriff (PDF)

Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study

Scientific reports, 2021-01, Vol.11 (1), p.634-634, Article 634

2021

Volltextzugriff (PDF)

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study

Breast cancer research : BCR, 2011-03, Vol.13 (2), p.R34-R34, Article R34

2011

Volltextzugriff (PDF)

The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients

PloS one, 2016-10, Vol.11 (10), p.e0163370-e0163370

2016

Volltextzugriff (PDF)

An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer

Cancer Research and Treatment, 2017, 49(3), , pp.569-577

2017

Volltextzugriff (PDF)

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer

Frontiers in oncology, 2021-11, Vol.11, p.783327-783327

2021

Volltextzugriff (PDF)

Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer

Breast cancer research and treatment, 2009-05, Vol.115 (2), p.335-342

2009

Volltextzugriff (PDF)

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer

PloS one, 2017-08, Vol.12 (8), p.e0182107-e0182107

2017

Volltextzugriff (PDF)

1 – 25 von 3.607

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.908)
Mit Volltextzugriff
(2.897)

Publikationsform

Sprache

Englisch
(3.042)
Koreanisch
(552)
Japanisch
(16)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.024)
Life Sciences & Biomedicine
(1.494)
Humans
(979)
Female
(732)
Male
(633)
Middle Aged
(582)
Aged
(486)
Adult
(416)
Technology
(369)
Oncology
(363)
Physical Sciences
(351)
Animals
(283)
Surgery
(242)
Treatment Outcome
(239)
Biological And Medical Sciences
(226)
Materials Science
(220)
Original
(215)
Retrospective Studies
(206)
Chemistry
(198)
Science & Technology - Other Topics
(194)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical Implications of CYP2D6 Genotypes Predictive of Tamoxifen Pharmacokinetics in Metastatic Breast Cancer

Preoperative Chemoradiation With Cetuximab, Irinotecan, and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: A Multicenter Phase II Study

Fatal Progression of Gorham Disease: A Case Report and Review of the Literature

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

Effects of Second and Subsequent Lines of Chemotherapy for Metastatic Breast Cancer

Genome‐wide association study of genetic variants related to anthracycline‐induced cardiotoxicity in early breast cancer

Mutation analysis using cell-free DNA for endocrine therapy in patients with HR+ metastatic breast cancer

Symptom perception and functioning in patients with advanced cancer

Metaplastic breast cancer: clinicopathological features and its prognosis

Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02

Web-Based Tailored Education Program for Disease-Free Cancer Survivors With Cancer-Related Fatigue: A Randomized Controlled Trial

Comparison of Sentinel Lymph Node Biopsy Guided by the Multimodal Method of Indocyanine Green Fluorescence, Radioisotope, and Blue Dye Versus the Radioisotope Method in Breast Cancer: A Randomized Controlled Trial

Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients

Efficacy of exemestane after nonsteroidal aromatase inhibitor use in metastatic breast cancer patients

Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer

Health-Related Quality of Life in Survivors With Breast Cancer 1 Year After Diagnosis Compared With the General Population: A Prospective Cohort Study

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study

The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients

An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer

Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)

Suchergebnisse filtern